Financing, Equity Capital Markets

Crinetics Pharmaceuticals, Inc.

09/23
|
$350.0 Million
Crinetics
Piper Sandler served as bookrunner for Crinetics Pharmaceuticals, Inc. on a follow-on offering -
Sub-Type
Follow-On Offering
Sub-Sector
Biopharma